Figure 3.

Proliferative responses to HIV p24 antigen. Proliferative response to HIV p24 Ag evaluated as A) cpm or B) SI, did not change over the 48 week study period in either subjects that received hepatitis B vaccine plus CpG (solid line; n = 19) or those that received hepatitis B vaccine without CpG (broken line; n = 19).

Angel et al. Journal of Immune Based Therapies and Vaccines 2008 6:4   doi:10.1186/1476-8518-6-4
Download authors' original image